5.13
price up icon0.98%   0.05
after-market Dopo l'orario di chiusura: 5.14 0.010 +0.19%
loading
Precedente Chiudi:
$5.08
Aprire:
$5.11
Volume 24 ore:
1.45M
Relative Volume:
0.56
Capitalizzazione di mercato:
$168.26M
Reddito:
-
Utile/perdita netta:
$-87.23M
Rapporto P/E:
-1.7273
EPS:
-2.97
Flusso di cassa netto:
$-82.77M
1 W Prestazione:
+1.18%
1M Prestazione:
+331.09%
6M Prestazione:
+308.76%
1 anno Prestazione:
-43.00%
Intervallo 1D:
Value
$4.94
$5.36
Intervallo di 1 settimana:
Value
$4.33
$5.36
Portata 52W:
Value
$0.8801
$9.935

Pepgen Inc Stock (PEPG) Company Profile

Name
Nome
Pepgen Inc
Name
Telefono
703-456-8000
Name
Indirizzo
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Name
Dipendente
62
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-08
Name
Ultimi documenti SEC
Name
PEPG's Discussions on Twitter

Confronta PEPG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PEPG
Pepgen Inc
5.13 349.19M 0 -87.23M -82.77M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
403.30 104.83B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.00 63.59B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.35 60.43B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
800.00 48.45B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
343.87 37.91B 4.56B -176.77M 225.30M -1.7177

Pepgen Inc Stock (PEPG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-09 Iniziato Guggenheim Buy
2024-12-16 Downgrade BofA Securities Neutral → Underperform
2024-07-31 Downgrade BofA Securities Buy → Neutral
2022-12-21 Iniziato H.C. Wainwright Buy

Pepgen Inc Borsa (PEPG) Ultime notizie

pulisher
01:01 AM

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

01:01 AM
pulisher
08:36 AM

Is PepGen Inc. trending in predictive chart modelsTrade Performance Summary & Safe Swing Trade Setups - newser.com

08:36 AM
pulisher
06:08 AM

Why PepGen Inc. stock remains resilientEarnings Overview Report & Long Hold Capital Preservation Plans - newser.com

06:08 AM
pulisher
05:21 AM

Is PepGen Inc. stock poised for growthWeekly Risk Summary & Daily Price Action Insights - newser.com

05:21 AM
pulisher
04:42 AM

Is PepGen Inc. reversing from oversold territoryWeekly Investment Report & AI Optimized Trade Strategies - newser.com

04:42 AM
pulisher
Oct 03, 2025

PepGen says FREEDOM clinical study achieves all key objectives - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

What data driven models say about PepGen Inc.’s futureWeekly Gains Report & Daily Profit Focused Screening - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can trapped investors hope for a rebound in PepGen Inc.Earnings Beat & Safe Swing Trade Setups - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using Bollinger Bands to evaluate PepGen Inc.2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can momentum traders help lift PepGen Inc.Market Growth Summary & Verified Entry Point Detection - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is PepGen Inc. stock gaining market shareJuly 2025 Recap & Pattern Based Trade Signal System - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle So - PharmiWeb.com

Oct 02, 2025
pulisher
Oct 02, 2025

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire

Oct 02, 2025
pulisher
Oct 01, 2025

Major Stakeholder Makes Bold Move with PepGen Inc. Stock Purchase! - TipRanks

Oct 01, 2025
pulisher
Oct 01, 2025

PepGen Highlights Progress in Therapy for DM1 - TipRanks

Oct 01, 2025
pulisher
Oct 01, 2025

PepGen Inc. Stock (PEPG) Opinions on Recent Insider Buying and Offering Closure - Quiver Quantitative

Oct 01, 2025
pulisher
Oct 01, 2025

PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Oct 01, 2025
pulisher
Sep 30, 2025

Massive Investment Alert: PepGen Inc. Stock Sees Major Buy-In! - TipRanks

Sep 30, 2025
pulisher
Sep 30, 2025

Anaphylaxis drives Larimar’s setback, weak efficacy behind MoonLake’s: Clinical Report - BioCentury

Sep 30, 2025
pulisher
Sep 30, 2025

PepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM Data - Insider Monkey

Sep 30, 2025
pulisher
Sep 30, 2025

PepGen (PEPG) Price Target Increased by 21.95% to 8.50 - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

Wedbush Cuts Price Target on PepGen to $8 From $9, Keeps Outperform Rating - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

What analysts say about PepGen Inc stockInstitutional Buying Trends & Follow Top Performers in the Community - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters Option to Purchase Additional Shares - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

What is Wedbush’s Estimate for PepGen FY2028 Earnings? - Defense World

Sep 29, 2025
pulisher
Sep 27, 2025

PepGen Stock Plummets on Secondary Offering News - timothysykes.com

Sep 27, 2025
pulisher
Sep 27, 2025

A Look at PepGen (PEPG) Valuation After Positive Clinical Data and $100M Equity Raise - Yahoo Finance

Sep 27, 2025
pulisher
Sep 27, 2025

PepGen Inc. Announces Public Offering Agreement - The Globe and Mail

Sep 27, 2025
pulisher
Sep 26, 2025

PepGen raises $115 million in public offering to fund clinical trials - Investing.com Nigeria

Sep 26, 2025
pulisher
Sep 26, 2025

PEPG News Today | Why did PepGen stock drop today? - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

MBX, uniQure among biotechs raising nine-figure sums: Public Equity Report - BioCentury

Sep 26, 2025

Pepgen Inc Azioni (PEPG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.43
price up icon 2.68%
$86.85
price up icon 0.66%
$33.56
price up icon 4.48%
$105.49
price up icon 0.94%
$157.16
price up icon 2.85%
biotechnology ONC
$343.87
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):